Key Takeaways
- • Delphinus Venture Capital, an Aarhus-based evergreen fund, has raised €80 million to finance research-driven startups across pre-seed through scale-up stages in East and Central Jutland.
- • The fund is established through a partnership between the Aarhus University Research Foundation, HEARTLAND, Norlys, and Salling Group, positioning it at the intersection of academic research, regional industry, and capital deployment.
- • The evergreen fund structure enables longer-term investment commitments and flexibility compared to traditional venture funds, differentiating Delphinus from conventional time-bound vehicles.
- • Mathias Brink Lorenz, formerly of the European Circular Bioeconomy Fund, leads the initiative as newly appointed CEO, bringing experience in sustainable venture investment.
- • The fund's proximity to Aarhus University, Aarhus University Hospital, and regional research environments enables identification and commercialization of academic research into scalable ventures.
Summary
Delphinus Venture Capital has officially launched with €80 million in committed capital to invest in research-driven startups across the East and Central Jutland region of Denmark. The fund was established through a strategic partnership between the Aarhus University Research Foundation, HEARTLAND, Norlys, and Salling Group, creating a regionally anchored vehicle focused on translating academic research into commercial ventures.
The fund's structure as an evergreen investment vehicle distinguishes it from conventional venture capital models. Unlike time-bound funds with predetermined exit windows, Delphinus's evergreen structure provides investors flexibility in capital deployment and enables longer-term commitment to portfolio companies. This approach allows the fund to support startups across the full investment lifecycle, from pre-seed through scale-up stages, without pressure to realize returns on an accelerated timeline—a meaningful differentiation in the venture capital market where traditional time constraints often force suboptimal exit decisions.
Mathias Brink Lorenz has been appointed CEO, bringing prior experience from the European Circular Bioeconomy Fund. His mandate is to lead the fund's operations and identify high-potential ventures emerging from the regional innovation ecosystem. Delphinus's operational base in Aarhus provides direct access to research environments at Aarhus University and Aarhus University Hospital, as well as other regional innovation hubs, enabling the fund to identify and support knowledge-based companies with strong scientific foundations.
The initiative addresses a strategic gap in regional venture capital availability and is designed to strengthen the connection between academic research, industrial application, and growth capital in East and Central Jutland. By positioning itself at this intersection, Delphinus aims to facilitate the commercialization of university-led research while providing sustained backing for entrepreneurs building ventures on a foundation of rigorous scientific work. The fund's focus on research-driven companies reflects a deliberate strategy to support ventures with differentiated intellectual property and defensible competitive advantages rooted in academic innovation.
The fund's structure as an evergreen investment vehicle distinguishes it from conventional venture capital models. Unlike time-bound funds with predetermined exit windows, Delphinus's evergreen structure provides investors flexibility in capital deployment and enables longer-term commitment to portfolio companies. This approach allows the fund to support startups across the full investment lifecycle, from pre-seed through scale-up stages, without pressure to realize returns on an accelerated timeline—a meaningful differentiation in the venture capital market where traditional time constraints often force suboptimal exit decisions.
Mathias Brink Lorenz has been appointed CEO, bringing prior experience from the European Circular Bioeconomy Fund. His mandate is to lead the fund's operations and identify high-potential ventures emerging from the regional innovation ecosystem. Delphinus's operational base in Aarhus provides direct access to research environments at Aarhus University and Aarhus University Hospital, as well as other regional innovation hubs, enabling the fund to identify and support knowledge-based companies with strong scientific foundations.
The initiative addresses a strategic gap in regional venture capital availability and is designed to strengthen the connection between academic research, industrial application, and growth capital in East and Central Jutland. By positioning itself at this intersection, Delphinus aims to facilitate the commercialization of university-led research while providing sustained backing for entrepreneurs building ventures on a foundation of rigorous scientific work. The fund's focus on research-driven companies reflects a deliberate strategy to support ventures with differentiated intellectual property and defensible competitive advantages rooted in academic innovation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.